Two weeks ago, our Spanish colleagues led the way and today our German study center also reached its 50% inclusion point. We are delighted to welcome our two newest patients. Under the leadership of principal investigator Dr Boris Schmitz, 60 patients are now taking part in the randomized controlled clinical TIMELY trial in Germany.
The TIMELY study is in full swing!
Previous
Previous
General Assembly Meeting in Spain
Next
Next